Pyxis Oncology, Inc. (PYXS)
4.41
+0.12
(+2.80%)
USD |
NASDAQ |
Dec 11, 16:00
4.40
-0.01
(-0.23%)
Pre-Market: 20:00
Pyxis Oncology Cash from Investing (Quarterly): 11.47M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 1.297M |
| Pfizer Inc. | -2.43B |
| Ironwood Pharmaceuticals, Inc. | -0.002M |
| Akebia Therapeutics, Inc. | -0.077M |
| PTC Therapeutics, Inc. | -289.62M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.28M |
| Cash from Financing (Quarterly) | -0.008M |
| Free Cash Flow | -72.45M |
| Free Cash Flow Per Share (Quarterly) | -0.2124 |
| Free Cash Flow to Equity (Quarterly) | -12.90M |
| Free Cash Flow to Firm (Quarterly) | -13.29M |
| Free Cash Flow Yield | -26.81% |